Merck & Co Inc

NYSE:MRK   3:59:59 PM EDT
71.94
-0.87 (-1.20%)
5:25:08 PM EDT: $72.00 +0.06 (+0.08%)
Products

FDA Says It Approves Belzutifan For Cancers Associated With Von Hippel-Lindau Disease

Published: 08/13/2021 15:13 GMT
Merck & Co Inc (MRK) - FDA Says It Approves Belzutifan for Cancers Associated With Von Hippel-lindau Disease.
((reuters.
Briefs@thomsonreuters.
Com;)).